Modelling the costs and effects of selective and universal hospital admission screening for methicillin-resistant Staphylococcus aureus
about
Comparison of strategies to reduce meticillin-resistant Staphylococcus aureus rates in surgical patients: a controlled multicentre intervention trialDynamic modeling for pandemic influenza.MRSA nasal carriage patterns and the subsequent risk of conversion between patterns, infection, and death.Cost and effects of different admission screening strategies to control the spread of methicillin-resistant Staphylococcus aureusTargeted rotavirus vaccination of high-risk infants; a low cost and highly cost-effective alternative to universal vaccination.Modelling the transmission of healthcare associated infections: a systematic review.Methicillin-resistant Staphylococcus aureus in Saarland, Germany: a statewide admission prevalence screening studyThe national one week prevalence audit of universal meticillin-resistant Staphylococcus aureus (MRSA) admission screening 2012.Effectiveness of hospital-wide methicillin-resistant Staphylococcus aureus (MRSA) infection control policies differs by ward specialty.Cost-benefit analysis from the hospital perspective of universal active screening followed by contact precautions for methicillin-resistant Staphylococcus aureus carriers.Trends in Staphylococcus aureus bacteraemia and impacts of infection control practices including universal MRSA admission screening in a hospital in Scotland, 2006-2010: retrospective cohort study and time-series intervention analysis.Cost Analysis of Universal Screening vs. Risk Factor-Based Screening for Methicillin-Resistant Staphylococcus aureus (MRSA)Impact of mupirocin resistance on the transmission and control of healthcare-associated MRSAEarly diagnosis of resistant pathogens: how can it improve antimicrobial treatment?Molecular epidemiology of community-associated methicillin-resistant Staphylococcus aureus in the genomic era: a cross-sectional study.Transmission rates, screening methods and costs of MRSA--a systematic literature review related to the prevalence in Germany.Methicillin-resistant staphylococci: implications for our food supply?Strict infection control leads to low incidence of methicillin-resistant Staphylococcus aureus bloodstream infection over 20 years.Optimal use of MRSASelect and PCR to maximize sensitivity and specificity of MRSA detection.Reply to O'Riordan et al.Multicenter evaluation of the Xpert MRSA NxG Assay for detection of methicillin resistant Staphylococcus aureus in nasal swabs.Screening of methicillin-resistant Staphylococcus aureus nasal colonization among elective surgery patients in referral hospital in Indonesia.Analysis of MRSA-attributed costs of hospitalized patients in Germany.Effizientes MRSA-ManagementEffizientes MRSA-Management
P2860
Q28680123-59767FA7-5DE7-41E9-88D1-30EC9671AEEFQ30419587-034621CD-F1BE-49CA-A760-B3D9921DE248Q34551656-DCCBCB34-1A31-4D96-88AB-1F0075407CE8Q34597876-09A90F2D-6A61-4C00-9A3C-89027123CE7AQ34690736-9FA3F8AF-05BA-4AEB-A331-CD790822D225Q34786520-C0E64C92-C19C-42E2-A57A-6F0CBC83AEB1Q34989450-D64877A0-295E-4168-88A1-203999A21DD3Q34999038-CAE2D6D0-FB9F-4C01-9A45-18489D993247Q35067961-64DEAC0C-B287-4704-8B49-4C8BBBEA8908Q35846925-ED58A64F-57F5-4719-BA76-C2BDC532D2F8Q36045103-C0489D3F-E596-45C4-AF93-51D0E88CB3BAQ36086990-767F98A4-F976-43CC-8527-908B00375D55Q36298961-EF11FE88-AC82-4192-BBE7-8CCD6D6BB7C3Q36845890-61427B0D-C412-416E-A010-0E2A8619FC25Q36879124-CD598769-84F6-4A52-8010-2781F28D4D45Q38008968-EB63E6C6-01FC-4323-97F9-4B7030E5C75AQ38068576-A9E4900E-5D19-40DF-991F-0C56CB49C9E7Q41345023-FE0C5D4B-FA42-45E1-A3EA-A8313E172918Q44645345-C2644544-BDD7-4F57-9504-1CFCB094B3F3Q46062358-6CAC7A89-7F84-4D44-AA5B-16E192D13605Q46585347-37AA6F96-A5C9-4CCC-B1BA-E2FA3CDEDC0DQ50111043-EAB57D5E-90D4-4167-9517-54EE171F0959Q50683657-B376F889-52E1-4B59-B946-3A56684FE368Q58570777-F656CE8C-8047-4DD3-9ACA-8AB71AFCAD8AQ58570795-226523FD-752C-42FB-A0C2-E8232608279A
P2860
Modelling the costs and effects of selective and universal hospital admission screening for methicillin-resistant Staphylococcus aureus
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Modelling the costs and effect ...... esistant Staphylococcus aureus
@ast
Modelling the costs and effect ...... esistant Staphylococcus aureus
@en
Modelling the costs and effect ...... esistant Staphylococcus aureus
@nl
type
label
Modelling the costs and effect ...... esistant Staphylococcus aureus
@ast
Modelling the costs and effect ...... esistant Staphylococcus aureus
@en
Modelling the costs and effect ...... esistant Staphylococcus aureus
@nl
prefLabel
Modelling the costs and effect ...... esistant Staphylococcus aureus
@ast
Modelling the costs and effect ...... esistant Staphylococcus aureus
@en
Modelling the costs and effect ...... esistant Staphylococcus aureus
@nl
P2093
P2860
P3181
P1433
P1476
Modelling the costs and effect ...... esistant Staphylococcus aureus
@en
P2093
Diarmuid Glynn
Gijs Hubben
Maarten Postma
Martin Bootsma
Michiel Luteijn
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0014783
P407
P577
2011-03-31T00:00:00Z